Traders Choice is a paid advertiser to do nothing more than pump XLIT-read the disclaimer is puts out. I beg to differ on the "strong reputation"
You didnt find anything in the amended 8K? I sure did, an audit of Bosch reveales ZERO revenues, $28 dollars, yes only $28 dollars in Total Members Equit as of May, Increased debt, just read it, its audited so very accurate.
IMO, this slide is just the beginning to much lower prices.
10-Q is late-they should file by tomorrow which will be a great read. IMO this is going to end very ugly. Time will tell.
According to the latest 10Q there is no value in the shares with $822.00 in cash and well over $70,000 in liabilities. And no reported revenues that I saw on the 10Q. http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10416254
I bailed just after the halt lifted @ 7.25 (average). I had just averaged down in late afternoon before the close, that does not happen too often but was sweet.
You need to do your homework, SCHE is an ETF not a mutual fund. It is the Schwab Emerging Markets ETF with IMO much better exposure to those markets than ECON. Furthermore Schwab clients trade the ETF's for free anytime.
With the upgrade and a lot of the float being held by large holders, CYTK could see $2.00 + today IMO.
Major holder list: http://finance.yahoo.com/q/mh?s=CYTK+Major+Holders
Piper Jaffray starts Cytokinetics at Overweight PT $4.00